October 27, 2015 Off

Allergan Acquires Rights To Ironwood’s Constella

By Dino Mustafić

Allergan plc and Ironwood Pharmaceuticals, Inc. have announced that Allergan has acquired rights to Constella (linaclotide) in the European Union, Switzerland, Turkey and the Commonwealth of Independent States from Almirall, S.A. and has also reacquired rights to Linzess (linaclotide) in Mexico from Almirall.

October 26, 2015 Off

Anavex joins NASDAQ

By Dino Mustafić

Anavex Life Sciences Corp., has announced it would be trading its common stock on the NASDAQ, an American/Canadian stock exchange, one…